Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM52PE
HR+
Luminal
Glycyl-H-1152
ROCK2
11852.16
uM
14.77880
13.0570
0.1470 0.1318 2.4703 0.1317
0.9476
1.2383
SUM52PE
HR+
Luminal
Glycyl-H-1152
ROCK2
10695.15
uM
4.74640
5.78340
-0.0819 -0.1663 1.4529 0.1768
0.9932
1.3520
SUM52PE
HR+
Luminal
GSK1070916
AURK
AURK
9878.001
uM
0.11784
0.35409
-0.5428 -0.5522 0.6762 0.5438
0.9799
1.3386
SUM52PE
HR+
Luminal
GSK1070916
AURK
AURK
9889.001
uM
0.20965
0.55738
-0.5741 -0.5720 0.7799 0.4868
0.9906
1.4638
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7539.092
uM
inf
inf
0.2651 0.2651 0.0000 0.2678
0.5391
1.2233
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7540.09
uM
inf
inf
-0.7641 -0.7641 0.0000 0.7833
0.5535
0.5702
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7541.098
uM
1.83130
4.36550
-0.7103 -0.8398 1.1347 0.4759
0.9625
1.6271
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7539.098
uM
2.49030
3.97350
-0.7635 -0.8176 2.0736 0.4865
0.9675
1.6240
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7541.091
uM
2.32450
9.19540
-0.8795 -1.0000 0.7989 0.4210
0.9868
1.4119
SUM52PE
HR+
Luminal
GSK1838705A
IGF1R
RTK
7541.071
uM
5.22250
8.00390
-0.8014 -0.8235 2.2799 0.4126
0.9881
1.3491
SUM52PE
HR+
Luminal
GSK461364
PLK1
PLK
9889.001
uM
0.00596
0.00650
-0.6000 -0.1837 3.5848 0.7728
0.9070
1.4638
SUM52PE
HR+
Luminal
GSK461364
PLK1
PLK
9878.001
uM
0.00532
0.00606
-0.2712 -0.1337 1.8195 0.7604
0.9501
1.3386
SUM52PE
HR+
Luminal
GSK923295
CENPE
Kinesin
9878.001
uM
0.02217
0.02482
-0.4420 -0.2648 3.7582 0.7026
0.9845
1.3386
SUM52PE
HR+
Luminal
GSK923295
CENPE
Kinesin
9889.001
uM
0.02221
0.02342
-0.2156 -0.1520 5.0000 0.6376
0.9886
1.4638
SUM52PE
HR+
Luminal
Ibandronate
FDPS
11852.143
uM
24.46870
27.570
-0.1219 -0.0911 1.4031 0.3170
0.9903
1.2284
SUM52PE
HR+
Luminal
Ibandronate
FDPS
10695.143
uM
44.74560
60.12140
-0.2519 -0.2540 1.3909 0.3183
0.9906
1.2894
SUM52PE
HR+
Luminal
ICRF-193
TOP2
TOP
10695.151
uM
1.65180
0.75962
0.2610 0.4363 2.6534 0.1764
0.8966
1.4773
SUM52PE
HR+
Luminal
ICRF-193
TOP2
TOP
11852.157
uM
5.23170
7.83140
0.1296 -0.1209 0.5369 0.1970
0.9101
1.4174
SUM52PE
HR+
Luminal
IKK16
IKK
NFKB
7539.093
uM
1.34480
3.16990
-0.9190 -1.0000 1.2813 0.5640
0.9664
1.5919
SUM52PE
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7540.09
uM
1.32850
1.48930
-0.8299 -0.1742 2.6167 0.6147
0.6850
0.5702
SUM52PE
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7539.092
uM
21.02320
55.97160
-0.9661 -1.0000 1.1219 0.3851
0.9904
1.2233
SUM52PE
HR+
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
7541.091
uM
25.05540
56.75860
-0.9595 -1.0000 1.3435 0.3630
0.9982
1.4119
SUM52PE
HR+
Luminal
Ispinesib
KSP
Kinesin
7541.067
uM
0.01768
0.05412
-0.9804 -0.7175 0.7956 0.8388
0.9347
1.4459
SUM52PE
HR+
Luminal
Ixabepilone
TUBB
TUBB
7541.095
uM
0.00031
0.00056
-0.9787 -0.3061 0.7899 1.0595
0.6623
1.4542
SUM52PE
HR+
Luminal
Ixabepilone
TUBB
TUBB
7539.095
uM
0.00619
0.15845
-0.9933 -1.0000 0.3387 0.8621
0.8539
1.1392